Search

Your search keyword '"Gastaldi, Matteo"' showing total 524 results

Search Constraints

Start Over You searched for: Author "Gastaldi, Matteo" Remove constraint Author: "Gastaldi, Matteo"
524 results on '"Gastaldi, Matteo"'

Search Results

1. Autoimmune encephalitis: what the radiologist needs to know.

12. Effect of Cement Type on the Concrete Resistance to Chloride Penetration over Time

13. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

15. Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis

19. Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience

21. Diagnostic accuracy of voluntary and stimulated neuromuscular jitter studies in ocular myasthenia gravis.

22. Fever and Neurological Signs

24. Overcoming therapeutic challenges: Successful management of a supposedly triple seronegative, refractory generalized myasthenia gravis patient with efgartigimod

25. Granulocyte Activation and Astrocyte Damage Markers in CSF Differentiate Acute NMOSD and MOGAD from MS (P9-14.004)

28. Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD

33. Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action.

35. Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study

36. Cell-based assays for the detection of MOG antibodies: a comparative study

38. Neurological complications due to copper deficiency in the context of Wilson disease treatment: a case report with long-term follow-up and review of the literature.

39. Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment inGBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol

43. Asynchronous combined central and peripheral demyelination (CCPD) in a girl with anti-MOG positivity: A case report and review of the literature

46. A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients

50. Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy

Catalog

Books, media, physical & digital resources